Archives for January 2015

ADHD, Autism, and Phenylketonuria

Acta Neurologica BelgicaResearchers at Assiut University have in collaboration with Geir Bjørklund evaluated the neuropsychological status in 78 children with early and continuously treated phenylketonuria (PKU) in Assiut, Upper Egypt. The article was on 10 January  2015 published online first in Acta Neurologica BelgicaThe first author of the study, Khaled Saad, is Associate Professor of Pediatrics at Assiut University, Assiut, Egypt. Bjørklund is founder and president of the Council for Nutritional and Environmental Medicine (CONEM).


Khaled Saad, Yasser Elserogy, Ahmed A. Abdel rahman, Abdulrahman Abdullah Al-Atram, Ismail L. Mohamad, Tarek T. H. ElMelegy, Geir Bjørklund, and Amira A. El-Houfy

ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt

Acta Neurol Belg. Article first published online: 10 JAN 2015. doi: 10.1007/s13760-014-0422-8 



The aim of this study is to evaluate the neuropsychological status in a cohort of children with early and continuously treated phenylketonuria in Assiut, Upper Egypt. The study was implemented in seventy-eight phenylketonuria (PKU) children. Only 34 patients met the inclusion criteria. Investigated patients were evaluated according to detailed history, neurological examination, Childhood Autism Rating Scale, full scale Intelligence Quotient, attention deficit hyperactivity disorder, electroencephalography and magnetic resonance imaging (MRI). This study concluded that the prognosis for early diagnosed children with PKU treated from the first weeks of life is generally good. However, they are at increased risk for neurological complications and behavioral problems. So, neonatal screening for PKU is highly recommended in Egypt, for early detection and management. In addition, neuropsychological and MRI assessments in PKU children should be done.



Unani Medicine: Its Origin and Development

The Unani system of medicine owes as its name suggests (Unani is an Arabic spelling of Ionian, meaning Greek), its origin to Greece. It was the Greek philosopher cum physician Hippocrates (c. 460 – c. 370 BC) who freed medicine from the realm of superstition and magic, and gave it the status of Science. The theoretical framework of Unani medicine is based on the teachings of Hippocrates. After Hippocrates, a number of other Greek scholars enriched the system considerably. Of them, Galen (129 – c. 200/c. 216 AD) stands out as the one who stabilized its foundation, on which Arab physicians like Muhammad ibn Zakariyā Rāzī (also known as Rhazes and Rasis) (854-925 AD) and Avicenna (980-1037 AD) constructed an imposing edifice.

Unani medicine got enriched by imbibing what best in the contemporary systems of traditional medicine in Egypt, Syria, Iraq, Persia, India, China, and other Middle East and Far East countries.

Read More


Selenium Tellurium Development Association’s 2015 Symposium

Early-bird rate of Euros 700 plus 19% VAT for all bookings made before January 30 2015 – a saving of Euros 200 on the full price

The Selenium Tellurium Development Association (STDA) is proud to announce that it is holding an international symposium at Steigenberger Hotel in Hamburg, Germany on 18-20 May 2015. This will be an opportunity to promote information and knowledge on selenium and tellurium.

This three-day event will enable everyone involved in these sectors to hear about the latest developments and research across a range of uses including glass, solar applications, infrared, animal feed, agriculture, water treatment and pharmacy.

The STDA is a non-profit membership corporation registered in the State of New York. Its activities are entirely financed by contributions from its member companies who come from Canada, USA, China, Chile, Australia, Belgium, Japan, Sweden, Russia, Germany, India and the Philippines.  The STDA retains expert consultants in the fields of bio-chemistry, environmental health and safety, public relations and industrial technology.

Please click here to view the programme and to find out more information about this event.

To register please fill out the form and email to or fax to +44 20 7820 0822. Please call +44 20 7840 0145 for more information about the conference.